Skip to main content


In the context of this particular year, biotech and medtech companies of our ecosystem have taken up many challenges and accelerated their development. 2020 is indeed a record-breaking year in fundraising for the life sciences ecosystem in Wallonia.

On this basis, BioWin and Euronext are pleased to invite you to their virtual event on the financing of biotech/medtech companies, on December 1st, 2020 from 4:30 pm to 6:00 pm.

Robert Taub, Founder and Chairman at Nyxoah, Olivier Delporte, CEO at Miracor Medical and Denis Bedoret, CEO at IMCYSE, as well as the following investment funds, Kurma Partners, Forbion and Endeavour Visionwill share their views and experiences.  

Discover the program: 

4:30 - 4:35 - Introduction 
Sylvie Ponchaut, Managing Director, BioWin
4:35 - 4:45 - Global presentation of the market situation
Benoît van den Hove, Head of Listing Belgium, Euronext
4:45 - 4:55 - Internationalization of shareholding & vision of the future
Olivier Delporte, CEO, Miracor Medical

4:55 - 5:05 - Pathway to the IPO 
Robert Taub, Founder & Chairman, NYXOAH

5:05 - 5:55 -  Panel discussion
Debate in the presence of Olivier Delporte (CEO, Miracor Medical), Denis Bedoret (CEO, IMCYSE) and representatives of investment funds, Juliette Audet (Principal, Forbion), Philippe Peltier (Partner France, Kurma Partners) and Damien Tappy (Co-Founder, President & Managing Partner, Endeavour Vision) 

Moderator : Jacques-Bernard Taste, President, Biotech Finances 

5:55 - 6:00 : Key take away messages and conclusion 
Sylvie Ponchaut, Managing Director, BioWin

* The event will be hosted in French



Any question regarding the event? Contact us !

Cta text
Register now !